Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HEMGN | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-11 |
mRNA | MS4A2 | CCLE | pan-cancer | AAC | 0.31 | 5e-11 |
mRNA | FHL3 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
mRNA | PTPN7 | GDSC1000 | pan-cancer | AAC | 0.4 | 7e-11 |
mRNA | ADAT2 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-11 |
mRNA | C11orf21 | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-11 |
mRNA | ERMAP | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
mRNA | GNA15 | GDSC1000 | pan-cancer | AAC | 0.27 | 9e-11 |
mRNA | MAP4K1 | GDSC1000 | pan-cancer | AAC | -0.36 | 9e-11 |
mRNA | SLC4A1 | CCLE | pan-cancer | AAC | 0.31 | 1e-10 |